First in-human PET study of 3 novel tau radiopharmaceuticals: RO6958948
Dean Foster Wong, Robert A. Comley, Hiroto Kuwabara, Paul B. Rosenberg, Susan M. Resnick, Susanne Ostrowitzki, Cristina Vozzi, Frank Boess, Esther S. Oh, Constantine George Lyketsos, Michael Honer, Luca B. Gobbi, Gregory Klein, Noble George, Lorena Gapasin, , Edilio Borroni
This paper reports the first human PET study of three novel tau radiopharmaceuticals, finding that [18F]RO-948 shows superior characteristics for tau pathology characterization in Alzheimer's disease.
Journal of Nuclear Medicine · May 4, 2018Peer-reviewedNeuroscience